1 Cancer stem cells in Osteosarcoma

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers. L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés. Cancer stem cells in Osteosarcoma Hannah Brown, Marta Tellez-Gabriel, Dominique Heymann

[1]  H. Kwon,et al.  Evaluating a therapeutic window for precision medicine by integrating genomic profiles and p53 network dynamics , 2018, Communications Biology.

[2]  R. Khokha,et al.  MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1 , 2017, Oncogene.

[3]  F. Verrecchia,et al.  TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression , 2016, Journal of clinical medicine.

[4]  A. Abarrategi,et al.  Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies , 2016, Stem cells international.

[5]  K. Pienta,et al.  The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer , 2016, Oncotarget.

[6]  W. Park,et al.  Deciphering intratumor heterogeneity using cancer genome analysis , 2016, Human Genetics.

[7]  R. Clarke,et al.  Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling , 2016, Oncotarget.

[8]  Anne-Marie Cleton-Jansen,et al.  Osteosarcoma Stem Cells Have Active Wnt/β‐catenin and Overexpress SOX2 and KLF4 , 2016, Journal of cellular physiology.

[9]  A. Cleton-Jansen,et al.  Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling. , 2016, Cancer letters.

[10]  Florian Engert,et al.  Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency , 2015, Nature Communications.

[11]  D. Placantonakis,et al.  Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells , 2015, Nature Communications.

[12]  P. Yuan,et al.  Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression , 2014, Oncogene.

[13]  B. Dawson,et al.  Notch activation as a driver of osteogenic sarcoma. , 2014, Cancer cell.

[14]  C. Swanton,et al.  Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine , 2014, Genome Biology.

[15]  M. Si,et al.  CD271+ Osteosarcoma Cells Display Stem-Like Properties , 2014, PloS one.

[16]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[17]  R. Khokha,et al.  High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures , 2014, Cancer medicine.

[18]  N. Kosaka,et al.  Clinical Relevance and Therapeutic Significance of MicroRNA‐133a Expression Profiles and Functions in Malignant Osteosarcoma‐Initiating Cells , 2014, Stem cells.

[19]  J. Huard,et al.  ALDH Activity Correlates with Metastatic Potential in Primary Sarcomas of Bone. , 2014, Journal of cancer therapy.

[20]  R. Clarke,et al.  Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity , 2013, Oncotarget.

[21]  C. Basilico,et al.  Perspectives on cancer stem cells in osteosarcoma. , 2013, Cancer letters.

[22]  Hua Wang,et al.  Transforming Growth Factor β1 Signal is Crucial for Dedifferentiation of Cancer Cells to Cancer Stem Cells in Osteosarcoma , 2013, Stem cells.

[23]  Wei Liu,et al.  CD133 expression in osteosarcoma and derivation of CD133⁺ cells. , 2013, Molecular medicine reports.

[24]  F. Papaccio,et al.  Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  H. Johnsen,et al.  Cancer stem cell definitions and terminology: the devil is in the details , 2012, Nature Reviews Cancer.

[26]  Yang Yao,et al.  CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study , 2012, Experimental and therapeutic medicine.

[27]  A. Paiva,et al.  Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line , 2012, BMC Cancer.

[28]  Zhuojing Luo,et al.  Side population cells isolated from human osteosarcoma are enriched with tumor‐initiating cells , 2011, Cancer science.

[29]  S. Orkin,et al.  Sox2 maintains self-renewal of tumor initiating cells in osteosarcomas , 2011, Oncogene.

[30]  Jingnan Shen,et al.  Enrichment of osteosarcoma stem cells by chemotherapy , 2011, Chinese journal of cancer.

[31]  F. Papaccio,et al.  Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[33]  Chia-Ying Lin,et al.  Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99‐1 cells based on high aldehyde dehydrogenase activity , 2011, International journal of cancer.

[34]  Toshio Mori,et al.  Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. , 2010, Oncology reports.

[35]  N. Agarwal,et al.  CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. , 2010, Cancer research.

[36]  Steven E. Brooks,et al.  Lung metastasis 21 years after initial diagnosis of osteosarcoma: a case report , 2009, Journal of medical case reports.

[37]  T. Yamashita,et al.  Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas , 2009, British Journal of Cancer.

[38]  Y. Takakura,et al.  Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. , 2009, International journal of oncology.

[39]  H. Okano,et al.  Tumor initiating potential of side population cells in human gastric cancer. , 2009, International journal of oncology.

[40]  C. Cavaliere,et al.  Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours , 2008, PloS one.

[41]  A. Corradin,et al.  The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. , 2008, Cancer research.

[42]  M. Shibuya,et al.  Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling , 2008, Oncogene.

[43]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[44]  Edward W Scott,et al.  Stem-like cells in bone sarcomas: implications for tumorigenesis. , 2005, Neoplasia.

[45]  M. de Rosa,et al.  Methods for cancer stem cell detection and isolation. , 2012, Methods in molecular biology.